EyePoint Pharmaceuticals (EYPT)
(Delayed Data from NSDQ)
$10.33 USD
+0.42 (4.24%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $10.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.55 |
Last EPS Surprise | -61.76% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.22 |
Next Year | -2.91 |
EPS (TTM) | -1.82 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.61M | 10.61M | 45.30M | 14.37M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 14.49M | 14.49M | 55.16M | 23.80M |
Low Estimate | 9.25M | 6.25M | 32.43M | 3.16M |
Year ago Sales | 9.11M | 15.20M | 46.02M | 45.30M |
Year over Year Growth Est. | 27.48% | -30.18% | -1.57% | -68.29% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.55 | -2.22 | -2.91 |
# of Estimates | 4 | 3 | 6 | 5 |
Most Recent Consensus | -0.48 | -0.48 | -1.99 | -2.42 |
High Estimate | -0.48 | -0.48 | -1.86 | -2.32 |
Low Estimate | -0.65 | -0.59 | -2.70 | -3.35 |
Year ago EPS | -0.61 | -0.33 | -1.82 | -2.22 |
Year over Year Growth Est. | 9.84% | -66.67% | -21.98% | -31.13% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.55 | -2.22 | -2.91 |
7 Days Ago | -0.55 | -0.55 | -2.22 | -2.91 |
30 Days Ago | -0.55 | -0.55 | -2.22 | -2.91 |
60 Days Ago | -0.51 | -0.51 | -2.15 | -2.86 |
90 Days Ago | -0.40 | -0.46 | -1.73 | -2.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.55 | -2.22 | -2.91 |
Zacks Consensus Estimate | -0.55 | -0.55 | -2.22 | -2.91 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.55 | -0.33 | -0.33 | -0.61 | NA |
Estimate | -0.34 | -0.60 | -0.62 | 0.41 | NA |
Difference | -0.21 | 0.27 | 0.29 | -1.02 | -0.17 |
Surprise | -61.76% | 45.00% | 46.77% | -248.78% | -54.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more